EPOETIN ALFA and DEATH

Overview

DEATH is the #11 most commonly reported adverse reaction for EPOETIN ALFA, manufactured by Amgen, Inc. There are 518 FDA adverse event reports linking EPOETIN ALFA to DEATH. This represents approximately 2.0% of all 25,704 adverse event reports for this drug.

Patients taking EPOETIN ALFA who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is a less commonly reported adverse event for EPOETIN ALFA, but still significant enough to appear in the safety profile.

Other Side Effects of EPOETIN ALFA

In addition to death, the following adverse reactions have been reported for EPOETIN ALFA:

• PRODUCT STORAGE ERROR — 1,123 reports
• ANAEMIA — 762 reports
• DYSPNOEA — 631 reports
• HAEMOGLOBIN DECREASED — 593 reports
• NAUSEA — 588 reports
• PAIN — 559 reports
• DIARRHOEA — 543 reports
• CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR — 542 reports
• VOMITING — 531 reports
• NEPHROGENIC SYSTEMIC FIBROSIS — 530 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does EPOETIN ALFA cause DEATH?

DEATH has been reported as an adverse event in 518 FDA reports for EPOETIN ALFA. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with EPOETIN ALFA?

DEATH accounts for approximately 2.0% of all adverse event reports for EPOETIN ALFA, making it a notable side effect.

What should I do if I experience DEATH while taking EPOETIN ALFA?

If you experience death while taking EPOETIN ALFA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages